The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.
Kedrion grows in North America as it completes acquisition of Prometic
Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency
Read all
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update
KEDRAB® is now the first and only HRIG available in the U.S. to be clinically studied in children
Read all
First patient enrolled in KIDCARES10
Kedrion Biopharma Pediatric Primary Immunodeficiency Study
Read all